Megeron en es it fr

Megeron Brand names, Megeron Analogs

Megeron Brand Names Mixture

  • No information avaliable

Megeron Chemical_Formula

C7H7NO3

Megeron RX_link

http://www.rxlist.com/cgi/generic2/canasa.htm

Megeron fda sheet

Megeron FDA

Megeron msds (material safety sheet)

Megeron MSDS

Megeron Synthesis Reference

No information avaliable

Megeron Molecular Weight

153.135 g/mol

Megeron Melting Point

283 oC

Megeron H2O Solubility

0.84 g/L at 20°C

Megeron State

Solid

Megeron LogP

1.012

Megeron Dosage Forms

Rectal suppository (500 mg or 1000 mg)

Megeron Indication

For the treatment of active ulcerative proctitis.

Megeron Pharmacology

Sulfasalazine has been used in the treatment of ulcerative colitis for over 55 years. It is split by bacterial action in the colon into sulfapyridine (SP) and mesalamine (5-ASA). It is thought that the mesalamine component only is therapeutically active in ulcerative colitis.

Megeron Absorption

20 to 30% absorbed following oral administration. 10 to 35% absorbed from the colon (rectal suppository) - extent of absorption is determined by the length of time the drug is retained in the colon.

Megeron side effects and Toxicity

Oral, mouse: LD50 = 3370 mg/kg; Oral, rat: LD50 = 2800 mg/kg; Skin, rabbit: LD50 = >5 gm/kg. There have been no documented reports of serious toxicity in man resulting from massive overdosing with mesalamine. Under ordinary circumstances, mesalamine absorption from the colon is limited.

Megeron Patient Information

Megeron Organisms Affected

Humans and other mammals